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Letter to the Editor 
 
 
Female gender and atrial fibrillation:  
 
An association with worse prognosis and outcomes  
 
 
regarding article “Gender-related differences and risk of cardiovascular morbidity and 
all-cause mortality in patients hospitalized with incident atrial fibrillation without 
concomitant diseases: A nationwide cohort study of 9519 patients” by Andersson L et al, 
International Journal of Cardiology; doi: 10.1016/j.ijcard.2014.09.092 
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To the Editor:  
 
Females with atrial fibrillation (AF) are at increased risk for ischemic stroke but have been 
under-represented in AF cohorts. Without anticoagulation, women are at higher risk than men for 
AF-related thromboembolic events (TE) but results are not consistent (1, 2). Interestingly, 
vascular complication rates after AF ablation had been recently shown to be also higher in 
females (3). Female sex has been included in the CHA2DS2-VASc score for assessing 
thromboembolic risk, which doubles in women between the ages of 55 and 65, the menopausal 
period, when estradiol levels decrease by about 60% (4). Following the menopause, a decline in 
endogenous estrogen receptors contributes to an up-regulated production of inflammatory 
cytokines, with further links to the hypercoagulable state (5). 
Thus, it was with great interest that we read the article by Andersson and co-workers (6) on the 
gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients 
with lone and idiopathic AF. Using by far the largest nationwide set of patients with incident AF 
and no other co-morbidity at the time of diagnosis, the authors demonstrated a two-fold risk of 
thromboembolic events and three-fold increased risk of heart failure in patients with AF 
irrespective of age and gender, as compared to controls. Furthermore, the authors found that 
women were at higher risk of stroke and transient ischemic attack than men. The annual rate of 
thromboembolic events in men and women between 55 and 64 years was 1.0-1.1% and in 
controls, 0.4% and 0.3%, respectively. This is in accordance with other observational and 
registry studies that demonstrated low annual rates of thromboembolism (stroke and systemic 
embolism, TE) in selected populations after AF catheter ablation, reaching event rates that are 
comparable to patients without AF (7). 
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The authors should be congratulated for their interesting findings on this topical and timely 
performed study that are in accordance with our research (8). Assessing gender-specific 
differences in thromboembolic risk post-ablation and the predictive risk factors for 
thromboembolism separately in females and males, we found that the incidence of 
thromboembolic events after AF catheter ablation is low in both genders. In contrast to the 
current study (6), there were no differences between thromboembolic events in males and 
females (1.2% versus 2.0%, p=0.128). In females, low ejection fraction (EF) and higher 
CHA2DS2-VASc score were independent predictors for thromboembolic risk, while renal 
dysfunction and all three stroke risk stratification scores, i.e. CHADS2, CHA2DS2-VASc, 
R2CHADS2, were associated with thromboembolic events risk in males. Because men constitute 
the large part of ablation cohorts, it was perhaps unsurprising to find an association between 
renal dysfunction and thromboembolic risk scores, as previously demonstrated (8).  
 
Heart failure has been associated with higher stroke rates in AF (9). Whilst impaired left 
ventricular ejection fraction is more commonly been used as an equivalent for the heart failure, 
AF patients with heart failure and normal (preserved) EF also have greater thromboembolic risk 
compared with only AF patients (10). Our finding that impaired EF is significant predictor for 
TE in females supports previous studies; however, the novel aspect is the importance of EF for 
risk assessment in women after catheter ablation. Demonstrating higher risk for of 
thromboembolic complications and development of heart failure in females with lone/idiopathic 
AF, the current study by Andersson et al (6) supports our observations and emphasizes the 
necessity of more careful gender-specific stroke risk assessment. 
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